Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease

Affiliations

¹ Division of Internal Medicine, Department of Medicine, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, USA.
² School of Pharmacy, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, USA.
³ Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, Madison, WI, 53705-2281, USA. fcaldera@medicine.wisc.edu.

Editorial

Dana Ley et al. Dig Dis Sci. 2019 Jul.

. 2019 Jul;64(7):1738-1739.

doi: 10.1007/s10620-019-05662-y.

¹ Division of Internal Medicine, Department of Medicine, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, USA.
² School of Pharmacy, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, USA.
³ Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, 1685 Highland Avenue, Madison, WI, 53705-2281, USA. fcaldera@medicine.wisc.edu.

No abstract available

Comment on

Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
Pratt PK Jr, Nunes D, Long MT, Farraye FA. Pratt PK Jr, et al. Dig Dis Sci. 2019 Jul;64(7):2031-2038. doi: 10.1007/s10620-019-05595-6. Epub 2019 Apr 3. Dig Dis Sci. 2019. PMID: 30945037 Free PMC article.

1. Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:619–633. - DOI - PubMed
1. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. CG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241–258. - DOI - PubMed
1. Pratt PK Jr, Weber HC, David N, et al. Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy. Inflamm Bowel Dis. 2018;24:380–386. - DOI - PubMed
1. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018;67:1–31. - DOI - PubMed - PMC
1. Pratt PK, Nunes D, Long MT, Farraye FA. Improved antibody response to three additional hepatitis B vaccine doses following primary vaccination failure in patients with inflammatory bowel disease. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-019-05595-6 .